UUֱ

subscribe

Montreal named world’s best student city

Montreal has ended Paris’s five-year stint as the world’s best student destination, according to global higher education analysts QS Quacquarelli Symonds.The fifth editionof theQS Best Student Citiesrankin
Published: 15 Feb 2017

Big Plans for Big Classes

UUֱ was one of 12 recipients of a mini-grant awarded today by the American Association of Universities (AAU) to support reform in undergraduate STEM (science, technology, engineering and mathematics) education.

Email address:
Published: 14 Feb 2017

A call for respect

Dear members of the UUֱ community,

Published: 13 Feb 2017

UUֱ steadfast in support for respectful discourse

UUֱ recently became aware of a disturbing communication on social media by a student. The University strongly condemns expressions of hatred or incitement to violence against any individual or group.

Published: 9 Feb 2017

Sex, drugs, and rock & roll chemistry in the brain

The same brain-chemical system that mediates feelings of pleasure from sex, recreational drugs, and food is also critical to experiencing musical pleasure, according to a study by UUֱ researchers published today in the Nature journal Scientific Reports.

Email address:
Published: 8 Feb 2017

Response to U.S. Executive Order restricting travel to the U.S. by citizens of seven countries

UUֱ is responding to U.S. President Donald Trump’s Executive Order restricting travel to the United States from seven Muslim-majority countries, Provost and Vice-Principal (Academic) Christopher Manfredi said Tuesday, Feb. 7.

Ѵǰ:/DZDz/-ܲԾٲ-DzԲ-ܲ-𳦳ܳپ-ǰ

Published: 7 Feb 2017

Tomislav Friščić awarded NSERC’s Steacie Memorial Fellowship

The Natural Sciences and Engineering Research Council of Canada has awarded an E.W.R Steacie Memorial Fellowship to Prof. Tomislav Friščić, to support his work in an innovative branch of chemistry that aims to develop environmentally friendly alternatives to solvent-based chemical processes.

Published: 7 Feb 2017

The making of Antarctica

One of the big mysteries in the scientific world is how the ice sheets of Antarctica formed so rapidly about 34 million years ago, at the boundary between the Eocene and Oligocene epochs.

There are 2 competing theories:

Email address:
Published: 31 Jan 2017

Why the bar needs to be raised for human clinical trials

Standards for authorizing first-time trials of drugs in humans are lax, and should be strengthened in several ways, UUֱ researchers argue in a paper published today in Nature.

Published: 30 Jan 2017

Protective wear inspired by fish scales

They started with striped bass. Over a two-year period the researchers went through about 50 bass, puncturing or fracturing hundreds of fish scales under the microscope, to try to understand their properties and mechanics better. “The people at the fish market must have wondered what we were up to,” saysFrançois Barthelatsmiling ruefully.” He teaches in the Dept.

Published: 23 Jan 2017

Bell Let’s Talk support for the Neuro will enhance mental health access for multicultural communities

Bell Let’s Talk today announced a donation of $250,000 to UUֱ’s Montreal Neurological Institute and Hospital – known as The Neuro – to fund the development of online mental health resources focused on the needs of multicultural communities.

Email address:
Published: 18 Jan 2017

A boost for artificial-intelligence research in Montreal

To help spur artificial-intelligence research in Montreal, Microsoft will provide a gift of $1 million to UUֱ.

Email address:
Published: 18 Jan 2017

A surprise advance in the treatment of adult cancers

A team of researchers at the Research Institute of the UUֱ Health Centre (RI-MUHC) has found an epigenetic modification that might be the cause of 15% of adult cancers of the throat linked to alcohol and tobacco use. This is a first in the field of epigenetics and the researchers are hopeful that the discovery can blaze a path in the development of new, targeted, more effective treatments that could arise over the next few years.

Published: 11 Jan 2017

Breakthrough in MS treatment

In separate clinical trials, a drug called ocrelizumab has been shown to reduce new attacks in patients with relapsing remitting multiple sclerosis (MS), and new symptom progression in primary progressive MS.

Email address:
Published: 9 Jan 2017

Pages

Back to top